Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Allergy Immunotherapies Market Analysis & Forecast 2019-2023: The Increasing Prevalence of Various Types of Allergies is Augmenting Growth (Over 7%) - ResearchAndMarkets.com

Research and Markets
Posted on: 06 Dec 18
The "Global Allergy Immunotherapies Market 2019-2023" report has been added to ResearchAndMarkets.com's offering. The allergy immunotherapies market is forecast register a CAGR of more than 7% by 2023. The latest trend gaining momentum in the market is the emerging drug development technologies. According to the report, one of the major drivers for this market is the increasing prevalence of various types of allergies. Further, the report states that one of the major factors hindering the growth of this market is the unknown pathogenesis. The emerging drug development technologies is likely to help the market grow during the forecast period. The recent advances in the immunotherapy drug development are helping the pharmaceutical companies to develop more efficient immunotherapies for the treatment of various allergies.

The increasing prevalence of various types of allergies across the globe is driving the allergy immunotherapies market. The growing occurrence of allergy is generated by the factors such as increasing pollution and augmented consumption of tobacco products like cigarettes, which is likely to boost the global allergy immunotherapy market.

The unknown pathogenesis of various allergies is the major challenge faced by the global allergy immunotherapies market. The unclear cause of allergy results in physicians misdiagnosing the allergen, and as a result the treatment prescribed is not as effective as it should be, and it often leads to adverse events.

With the presence of a considerable number of companies, this market appears to be fragmented. The current advances in the immunotherapy drug development are helping the pharmaceutical companies to develop more effective immunotherapies for the treatment of various allergies. Several established allergy immunotherapy manufacturers are striving for their share of the global allergy immunotherapies market, and the new players must differentiate themselves to gain vital traction over their competitors. Key Players
  • ALK
  • Allergy Therapeutics
  • HAL Allergy
  • Merck
  • Stallergenes Greer

Topics Covered

1. Executive Summary

2. Scope of the Report

3. Market Landscape

4. Market Sizing

5. Five Forces Analysis

6. Market Segmentation by Product

7. Customer Landscape

8. Geographic Landscape

9. Decision Framework

10. Drivers and Challenges

11. Market Trends

12. Vendor Landscape

13. Vendor Analysis For more information about this report visit https://www.researchandmarkets.com/research/7wj84v/global_allergy?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181206005681/en/

Business Wire
www.businesswire.com

Last updated on: 06/12/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.